SCHEMBL3136318

SCHEMBL3136318

CC(=O)[C@@]1(Br)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 9/20 0.73
▸ SHBG P04278 8/20 0.73
▸ SERPINA6 P08185 7/20 0.73
▸ NR3C1 P04150 6/20 0.73
▸ SMN1; SMN2 Q16637 6/20 0.73
▸ BLM P54132 4/20 0.73
▸ CYP2C19 P33261 3/20 0.73
▸ MEN1 O00255 3/20 0.73
▸ KMT2A Q03164 3/20 0.73
▸ MAPT P10636 3/20 0.73
▸ ADORA3 P0DMS8 2/20 0.73
▸ SLC6A3 Q01959 2/20 0.73
▸ MAPK3 P27361 1/20 0.73
▸ PGR P06401 5/20 0.69
▸ ALDH1A1 P00352 3/20 0.69
▸ ADRA1A P35348 1/20 0.69
▸ HTR2B P41595 1/20 0.69
▸ CYP17A1 P05093 1/20 0.64
▸ HSD17B10 Q99714 7/20 0.63
▸ TSHR P16473 4/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18891189 0.86 SHBG (0.77) LMNASHBGSERPINA6NR3C1SMN1; SMN2
SCHEMBL18891198 0.86 SHBG (0.77) LMNASHBGSERPINA6NR3C1SMN1; SMN2
SCHEMBL8093443 0.86 SHBG (0.77) LMNASHBGSERPINA6NR3C1SMN1; SMN2
SCHEMBL14150039 0.86 SHBG (0.77) LMNASHBGSERPINA6NR3C1SMN1; SMN2
SCHEMBL8937171 0.85 LMNA (0.72) LMNASHBGSERPINA6NR3C1SMN1; SMN2
SCHEMBL8853536 0.85 LMNA (0.72) LMNASHBGSERPINA6NR3C1SMN1; SMN2
Hydroxyprogesterone SCHEMBL23456341 0.85 LMNA (1.00) LMNASHBGSERPINA6NR3C1SMN1; SMN2
Hydroxyprogesterone SCHEMBL13558389 0.85 LMNA (1.00) LMNASHBGSERPINA6NR3C1SMN1; SMN2
Hydroxyprogesterone SCHEMBL265609 0.85 LMNA (1.00) LMNASHBGSERPINA6NR3C1SMN1; SMN2
Hydroxyprogesterone SCHEMBL18261234 0.85 LMNA (1.00) LMNASHBGSERPINA6NR3C1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9180132-B2 Antimicrobial cationic steroids and methods of use THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-11-10 — — US disclosed
US-9056048-B2 Synthesis and use of cationic steroids for anti-inflammatory drug therapy THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2015-06-16 — — US disclosed
US-20130137668-A1 Antimicrobial Cationic Steroids and Methods of Use THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2013-05-30 — — US disclosed
WO-2010062562-A1 SYNTHESIS AND USE OF CATIONIC STEROIDS FOR ANTI-INFLAMMATORY DRUG THERAPY THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-06-03 — — WO disclosed
US-20090124591-A1 Synthesis and Use of Cationic Steroids for Anti-Inflammatory Drug Therapy THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2009-05-14 — — US disclosed
US-7442386-B2 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2008-10-28 — — US disclosed
EP-1424998-A4 SYNTHESIS AND USE OF REAGENTS FOR IMPROVED DNA LIPOFECTION AND/OR SLOW RELEASE PRODRUG AND DRUG THERAPIES UNIV PENNSYLVANIA (US) 2005-11-23 — — EP disclosed
US-20050069577-A1 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies TRUSTEES OF UNIVERSITY OF PENNSYLVANIA 2005-03-31 — — US disclosed
EP-1424998-A1 SYNTHESIS AND USE OF REAGENTS FOR IMPROVED DNA LIPOFECTION AND/OR SLOW RELEASE PRODRUG AND DRUG THERAPIES The Trustees of The University of Pennsylvania (US) 2004-06-09 — — EP disclosed
WO-2003015757-A1 SYNTHESIS AND USE OF REAGENTS FOR IMPROVED DNA LIPOFECTION AND/OR SLOW RELEASE PRODRUG AND DRUG THERAPIES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2003-02-27 — — WO disclosed
Send feedback